Select Your Region
- Manufacturer: Evonik Corporation
- Product Line: RESOMER® Polymers
- Product: RESOMER® RG Polymers
- Industries: Pharmaceuticals
- Authorized Countries: Canada | United States
RESOMER® RG 504 H
RESOMER® RG 504 H is a solvent-purified poly(D,L-lactide-co-glycolide) polymer with an acid end group and inherent viscosity of 0.45-0.60 dL/g. RESOMER® RG 504 H has a degradation period of 3 months maximum.
Quantity
Documents
Specifications
Physical state: Solid
Form: Powder granules
Color: Various
Inherent viscosity (dl/g): 0.45─0.60
Degradation time: <3 months
CAS No. 26780-50-7
Primary Chemistry:
Poly(D,L-lactide-co-glycolide)
- Manufacturer: Evonik Corporation
- Product Line: RESOMER® Polymers
- Product: RESOMER® RG Polymers
- Industries: Pharmaceuticals
- Authorized Countries: Canada | United States
Manufacturer
Product Line
Product
Industries
Authorized Countries
Canada
United States
Overview
RESOMER® RG 504 H is an acid-terminated version of RESOMER® RG 504 poly(D,L-lactide-co-glycolide) copolymer containing a blend of 50 mol % D,L-Lactide and 50 mol % Glycolide for pharmaceutical controlled release. This lactide polymer provides specialty delayed release capabilities ensuring the controlled release of peptides, microparticles, small molecules, proteins, and more in in-situ depot formulations, long-acting medication delivery systems, and drug-loaded implants.
RESOMER® RG 504 H complies with FDA, GMP, EHS, DIN ISO 9001, MAF, and DMF regulations.
RESOMER® polymers have been purified for a reduced residual monomer content and are available in a variety of molecular weights and viscosity ranges to meet application needs. All polymer properties can also be adjusted to match formulation requirements.
Specifications
Physical state: Solid
Form: Powder granules
Color: Various
Inherent viscosity (dl/g): 0.45─0.60
Degradation time: <3 months
CAS No. 26780-50-7
Primary Chemistry:
Poly(D,L-lactide-co-glycolide)
Features & Benefits
- Solvent-purified co-polymer
- 50:50 D,L-lactide:Glycolide ratio
- Free carboxylic acid terminated
- 3-month degradation period
- Bioabsorbable
- Biodegradable
- Processed by injection molding
- Completely metabolized by the body
- Ideal for terminal sterilization
- Suitable for use with small molecules, peptides, proteins, and other substances
Applications
Controlled release applications
Microparticles and drug-loaded implants
Long acting medication delivery formulations
Related Applications
Pharmaceuticals
Related Functions
Pharmaceuticals
ChemPoint Is Here to Help
Are you in the correct region?
We’ve detected that you are located in a different region than the region selected on the website. Would you like to change your region?
Current Region: English - United States
